Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion description "[The genes E-cadherin (ECAD), transmembrane protein with epidermal growth factor-like and 2 follistatin-like domains 2 (TMEFF2), retinoic acid receptor beta (RAR?), and O-6 methylguanine DNA methyltransferase (MGMT) had high sensitivity (>75%) and specificity for the detection of oral cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion evidence source_evidence_literature NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion SIO_000772 22252571 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion wasDerivedFrom befree-20140225 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion wasGeneratedBy ECO_0000203 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.